NCT03937635 | EAA173 | OPEN – Green Bay Oncology

NCT Number: NCT03937635

Protocol ID: EAA173

Sponsor: OPEN

Disease Site: Multiple Myeloma

Disease Category: Multiple Myeloma

Detail: Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)

Interested in participating in this trial?

Clinical Trial

First Name

Last Name

Phone

Preferred Contact Method:

Preferred Location:

Patient Type:

Current Patient New Patient

Interested in:

Cancer Clinical Trial Blood Disorder Clinical Trial

Disease Site:

Disease Category

The National Clinical Trial (NTC) is assigned by the National Library of Medicine when a new study appears in the clinical trials database.

ex: NCT0526225 | GY026 | NRG

Any unique identifier assigned to the protocol by the sponsor.

ex: NCT0526225 | GY026 | NRG

A sponsor is an individual, institution, company or organization that takes the responsibility to initiate, manage and/or finance the clinical trial.

ex: NCT0526225 | GY026 | NRG